240 related articles for article (PubMed ID: 3291528)
21. Synergistic stimulatory effect of glucagon-like peptide-1 (7-36) amide and glucose-dependent insulin-releasing polypeptide on the endocrine rat pancreas.
Fehmann HC; Göke B; Göke R; Trautmann ME; Arnold R
FEBS Lett; 1989 Jul; 252(1-2):109-12. PubMed ID: 2668027
[TBL] [Abstract][Full Text] [Related]
22. Reduced insulinotropic effects of glucagonlike peptide I-(7-36)-amide and gastric inhibitory polypeptide in isolated perfused diabetic rat pancreas.
Suzuki S; Kawai K; Ohashi S; Mukai H; Murayama Y; Yamashita K
Diabetes; 1990 Nov; 39(11):1320-5. PubMed ID: 2146178
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin (CCK)-33 stimulates insulin secretion from the perfused rat pancreas: studies on the structure-activity relationship.
Sandberg E; Ahrén B; Tendler D; Efendic S
Pharmacol Toxicol; 1988 Jul; 63(1):42-5. PubMed ID: 3041399
[TBL] [Abstract][Full Text] [Related]
24. Vasoactive intestinal polypeptide stimulates cholecystokinin secretion in perfused rat duodenum.
Funakoshi A; Nakano I; Miyazaki K
Tohoku J Exp Med; 1989 Jan; 157(1):55-9. PubMed ID: 2711376
[TBL] [Abstract][Full Text] [Related]
25. Pancreatic polypeptide, glucagon and insulin secretion from the isolated perfused canine pancreas.
Adrian TE; Bloom SR; Hermansen K; Iversen J
Diabetologia; 1978 Jun; 14(6):413-7. PubMed ID: 669104
[TBL] [Abstract][Full Text] [Related]
26. Interaction of cholecystokinin and vasoactive intestinal polypeptide on function of mouse pancreatic acini in vitro.
Burnham DB; McChesney DJ; Thurston KC; Williams JA
J Physiol; 1984 Apr; 349():475-82. PubMed ID: 6204039
[TBL] [Abstract][Full Text] [Related]
27. Physiological augmentation of amino acid-induced insulin secretion by GIP and GLP-I but not by CCK-8.
Fieseler P; Bridenbaugh S; Nustede R; Martell J; Orskov C; Holst JJ; Nauck MA
Am J Physiol; 1995 May; 268(5 Pt 1):E949-55. PubMed ID: 7762650
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of insulin and somatostatin secretion and stimulation of glucagon release by homologous galanin in perfused rat pancreas.
Miralles P; Peiró E; Dégano P; Silvestre RA; Marco J
Diabetes; 1990 Aug; 39(8):996-1001. PubMed ID: 1695589
[TBL] [Abstract][Full Text] [Related]
29. Proglumide (gastrin and cholecystokinin receptor antagonist) inhibits insulin secretion in vitro.
Verspohl EJ; Wunderle G; Ammon HP; Williams JA; Goldfine ID
Naunyn Schmiedebergs Arch Pharmacol; 1986 Mar; 332(3):284-7. PubMed ID: 3012373
[TBL] [Abstract][Full Text] [Related]
30. Secretory effects of VIP on isolated perfused porcine pancreas.
Jensen SL; Fahrenkrug J; Holst JJ; Nielsen OV; Schaffalitzky de Muckadell OB
Am J Physiol; 1978 Oct; 235(4):E387-91. PubMed ID: 696859
[TBL] [Abstract][Full Text] [Related]
31. Effects of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-I-(7-36) on insulin secretion.
Jia X; Brown JC; Ma P; Pederson RA; McIntosh CH
Am J Physiol; 1995 Apr; 268(4 Pt 1):E645-51. PubMed ID: 7733263
[TBL] [Abstract][Full Text] [Related]
32. Comparison of GLP-1 (7-36amide) and GIP on release of somatostatin-like immunoreactivity and insulin from the isolated rat pancreas.
Schmid R; Schusdziarra V; Aulehner R; Weigert N; Classen M
Z Gastroenterol; 1990 Jun; 28(6):280-4. PubMed ID: 2238756
[TBL] [Abstract][Full Text] [Related]
33. Independence of GIP-induced insulin secretion from sympathetic and parasympathetic innervation in the isolated perfused rat pancreas.
von Schönfeld J; Müller MK; Rünzi M; Goebell H
Int J Pancreatol; 1991 Sep; 10(1):31-8. PubMed ID: 1757729
[TBL] [Abstract][Full Text] [Related]
34. Effects of hydrocortisone on glucose- and cholecystokinin-induced insulin release from the isolated perfused rat pancreas.
Otsuki M; Okabayashi Y; Ohki A; Suehiro I; Nakamura T; Fujii M; Tani S; Baba S
Pancreas; 1988; 3(4):459-64. PubMed ID: 3050978
[TBL] [Abstract][Full Text] [Related]
35. Effect of glucagon-like peptide-1 on insulin secretion.
Shima K; Hirota M; Ohboshi C
Regul Pept; 1988 Aug; 22(3):245-52. PubMed ID: 3051138
[TBL] [Abstract][Full Text] [Related]
36. Interaction of gastric inhibitory polypeptide and arginine with glucose in the perfused pancreas of rats treated with triiodothyronine.
Mueller MK; Pederson RA; Brown JC
Can J Physiol Pharmacol; 1982 Mar; 60(3):297-301. PubMed ID: 7042057
[TBL] [Abstract][Full Text] [Related]
37. Glucagon-like peptide-1, but not glucose-dependent insulinotropic peptide, inhibits glucagon secretion via somatostatin (receptor subtype 2) in the perfused rat pancreas.
de Heer J; Rasmussen C; Coy DH; Holst JJ
Diabetologia; 2008 Dec; 51(12):2263-70. PubMed ID: 18795252
[TBL] [Abstract][Full Text] [Related]
38. Insulinotropic properties of synthetic human gastric inhibitory polypeptide in man: interactions with glucose, phenylalanine, and cholecystokinin-8.
Nauck M; Schmidt WE; Ebert R; Strietzel J; Cantor P; Hoffmann G; Creutzfeldt W
J Clin Endocrinol Metab; 1989 Sep; 69(3):654-62. PubMed ID: 2668324
[TBL] [Abstract][Full Text] [Related]
39. Effect of sulfation of CCK-8 on its stimulation of the endocrine and exocrine secretion from the isolated perfused porcine pancreas.
Jensen SL; Holst JJ; Nielsen OV; Rehfeld JF
Digestion; 1981; 22(6):305-9. PubMed ID: 6277714
[TBL] [Abstract][Full Text] [Related]
40. Distribution of vasoactive intestinal polypeptide, neuropeptide-Y and substance P and their effects on insulin secretion from the in vitro pancreas of normal and diabetic rats.
Adeghate E; Ponery AS; Pallot DJ; Singh J
Peptides; 2001 Jan; 22(1):99-107. PubMed ID: 11179603
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
